Other News To Note
Tuesday, October 23, 2012
Ligand Pharmaceuticals Inc., of San Diego, said it will receive a $2 million milestone payment from Merck & Co. Inc., of Whitehouse Station, N.J., under the terms of a development and license collaboration for the development of dinaciclib.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.